Martin Haslbeck Selected Research

Hypoxia (Hypoxemia)

1/2020

An anti-inflammatory eicosanoid switch mediates the suppression of type-2 inflammation by helminth larval products.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Haslbeck Research Topics

Disease

2	Cataract (Cataracts) 01/2021 - 01/2016
2	Neoplasms (Cancer) 10/2016 - 10/2010
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2010 - 11/2010
2	Rheumatoid Arthritis 12/2010 - 01/2007
1	Epilepsy (Aura) 01/2022
1	Cysts 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Carcinogenesis 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Adenocarcinoma 01/2021
1	Inflammation (Inflammations) 01/2020
1	Eosinophilia 01/2020
1	Asthma (Bronchial Asthma) 01/2020
1	Hypersensitivity (Allergy) 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2018
1	Neuromuscular Diseases (Neuromuscular Disease) 01/2017
1	Alzheimer Disease (Alzheimer's Disease) 10/2016
1	Dementia (Dementias) 10/2016
1	Ovarian Neoplasms (Ovarian Cancer) 10/2016
1	Fever (Fevers) 01/2014
1	Infections 01/2014
1	Proteostasis Deficiencies 10/2010
1	Muscular Diseases (Myopathy) 08/2009
1	Amyloid Plaque 11/2007
1	Endotoxemia 08/2007
1	Sepsis (Septicemia) 01/2007
1	Paralysis (Palsy) 05/2004

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2004
3	Crystallins (Crystallin)IBA 01/2021 - 08/2009
2	Dinoprostone (PGE2)FDA Link 01/2022 - 01/2020
2	Glutamate DehydrogenaseIBA 01/2022 - 01/2020
2	EnzymesIBA 01/2020 - 01/2014
2	Molecular Chaperones (Chaperone, Molecular)IBA 10/2016 - 10/2010
1	LipidsIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Therapeutic UsesIBA 01/2021
1	ProteomeIBA 01/2021
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 01/2021
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	EicosanoidsIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 05/2018
1	oxidized low density lipoproteinIBA 05/2018
1	Protein CIBA 10/2016
1	Amyloid (Amyloid Fibrils)IBA 10/2016
1	Peptides (Polypeptides)IBA 10/2016
1	MicellesIBA 10/2016
1	Pharmaceutical PreparationsIBA 10/2016
1	glucose-regulated proteinsIBA 12/2010
1	CalnexinIBA 12/2010
1	AntibodiesIBA 12/2010
1	Small Heat-Shock ProteinsIBA 10/2010
1	Protein Isoforms (Isoforms)IBA 08/2009
1	alpha-Crystallins (alpha-Crystallin)IBA 08/2009
1	Extracellular Matrix ProteinsIBA 11/2007
1	ClusterinIBA 11/2007
1	Amyloid beta-PeptidesIBA 11/2007
1	Membrane Proteins (Integral Membrane Proteins)IBA 08/2007
1	LipopolysaccharidesIBA 08/2007
1	HMGB1 Protein (HMG1)IBA 01/2007

Therapy/Procedure

2	Therapeutics 01/2020 - 10/2016
1	Lenses 01/2021
1	Intraperitoneal Injections 08/2007